Literature DB >> 18054688

Effects of iron supplementation on attention deficit hyperactivity disorder in children.

Eric Konofal1, Michel Lecendreux, Juliette Deron, Martine Marchand, Samuele Cortese, Mohammed Zaïm, Marie Christine Mouren, Isabelle Arnulf.   

Abstract

Iron deficiency has been suggested as a possible contributing cause of attention deficit hyperactivity disorder (ADHD) in children. This present study examined the effects of iron supplementation on ADHD in children. Twenty-three nonanemic children (aged 5-8 years) with serum ferritin levels <30 ng/mL who met DSM-IV criteria for ADHD were randomized (3:1 ratio) to either oral iron (ferrous sulfate, 80 mg/day, n = 18) or placebo (n = 5) for 12 weeks. There was a progressive significant decrease in the ADHD Rating Scale after 12 weeks on iron (-11.0 +/- 13.9; P < 0.008), but not on placebo (3.0 +/- 5.7; P = 0.308). Improvement on Conners' Parent Rating Scale (P = 0.055) and Conners' Teacher Rating Scale (P = 0.076) with iron supplementation therapy failed to reach significance. The mean Clinical Global Impression-Severity significantly decreased at 12 weeks (P < 0.01) with iron, without change in the placebo group. Iron supplementation (80 mg/day) appeared to improve ADHD symptoms in children with low serum ferritin levels suggesting a need for future investigations with larger controlled trials. Iron therapy was well tolerated and effectiveness is comparable to stimulants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18054688     DOI: 10.1016/j.pediatrneurol.2007.08.014

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  65 in total

Review 1.  Iron for restless legs syndrome.

Authors:  Lynn M Trotti; Srinivas Bhadriraju; Lorne A Becker
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

2.  Ferritin and hyperactivity ratings in attention deficit hyperactivity disorder.

Authors:  Pinar Oner; Ozgur Oner; Fatih M Azik; Esra Cop; Kerim M Munir
Journal:  Pediatr Int       Date:  2012-07-19       Impact factor: 1.524

3.  Serum ferritin and amphetamine response in youth with attention-deficit/hyperactivity disorder.

Authors:  Chadi Calarge; Cristan Farmer; Robert DiSilvestro; L Eugene Arnold
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-12       Impact factor: 2.576

4.  Iron status in toddlerhood predicts sensitivity to psychostimulants in children.

Authors:  Catharyn A Turner; Diqiong Xie; Bridget M Zimmerman; Chadi A Calarge
Journal:  J Atten Disord       Date:  2010-10-26       Impact factor: 3.256

Review 5.  Sleep Problems in Children with Attention Deficit/Hyperactivity Disorder: Current Status of Knowledge and Appropriate Management.

Authors:  Ming-Horng Tsai; Jen-Fu Hsu; Yu-Shu Huang
Journal:  Curr Psychiatry Rep       Date:  2016-08       Impact factor: 5.285

6.  Postmortem and imaging based analyses reveal CNS decreased myelination in restless legs syndrome.

Authors:  James R Connor; Padmavathi Ponnuru; Byeong-Yeul Lee; Gerald D Podskalny; Shoaib Alam; Richard P Allen; Christopher J Earley; Qing X Yang
Journal:  Sleep Med       Date:  2011-05-12       Impact factor: 3.492

7.  Effect of Ferritin on Short-Term Treatment Response in Attention Deficit Hyperactivity Disorder.

Authors:  Pinar Oner; Ozgur Oner; Esra Cop; Kerim M Munir
Journal:  Klinik Psikofarmakol Bulteni       Date:  2016-11-08

8.  Transferrin in korean children with attention deficit hyperactivity disorder.

Authors:  Ho Jang Kwon; Myung Ho Lim; Mina Ha; Eun Jung Kim; Seung Jin Yoo; Jong Wan Kim; Ki Chung Paik
Journal:  Psychiatry Investig       Date:  2011-11-25       Impact factor: 2.505

Review 9.  Diagnosis and management of restless legs syndrome in children.

Authors:  Narong Simakajornboon; Leila Kheirandish-Gozal; David Gozal
Journal:  Sleep Med Rev       Date:  2009-01-31       Impact factor: 11.609

10.  Iron deficiency in pediatric patients in long-term risperidone treatment.

Authors:  Chadi Albert Calarge; Ekhard E Ziegler
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-03-12       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.